Can testosterone replacement therapy cause visual disturbances in a patient with traumatic brain injury? | Rounds Can testosterone replacement therapy cause visual disturbances in a patient with traumatic brain injury? | Rounds
Loading...

Can testosterone replacement therapy cause visual disturbances in a patient with traumatic brain injury?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Testosterone Replacement Therapy and Visual Disturbances

Testosterone replacement therapy (TRT) can be associated with visual disturbances, including blurred vision and transient visual obscurations, based on case reports and small case series. [1], [2]

Evidence Supporting TRT-Associated Visual Disturbances

A case report described central serous chorioretinopathy (CSR) occurring shortly after intramuscular testosterone injection, with symptom resolution and recurrence after subsequent injection. [1]

A published case report and literature review of intracranial hypertension associated with exogenous testosterone reported ocular symptoms including transient visual obscurations and blurred vision. [2]

Mechanisms Relevant to Visual Symptoms

Visual symptoms from TRT may occur through mechanisms affecting retinal function and through mechanisms that increase intracranial pressure. [1], [2]

Clinical Presentation Patterns After TRT Initiation

TRT-associated intracranial hypertension commonly presents with headache plus ocular symptoms such as transient visual obscurations and blurred vision. [2]

TRT-associated CSR may present with blurred vision temporally related to testosterone dosing, with improvement after changing the testosterone regimen in a reported case. [1]

Evaluation of New Visual Disturbances in a TRT-Treated Patient With TBI

New or worsening visual symptoms after starting TRT or after a dose change should prompt urgent clinical assessment for neuro-ophthalmic and retinal causes. [1], [2]

TRT should be held and an urgent ophthalmology and/or neuro-ophthalmology evaluation should be pursued when visual disturbances occur in close temporal relation to treatment initiation or dose escalation, consistent with the reported approach in TRT-associated CSR. [1]

Targeted Diagnostic Considerations

Evaluation should include assessment for retinal disease consistent with CSR when blurred vision occurs after TRT dosing. [1]

Evaluation should include assessment for intracranial hypertension when blurred vision co-occurs with headache or other signs/symptoms consistent with increased intracranial pressure. [2]

Patient-Specific Risk Context in Traumatic Brain Injury

Traumatic brain injury increases baseline risk for neurologic sequelae, so new visual disturbances during TRT should be treated as potentially clinically significant until alternative causes are excluded. [2]

Related Questions